Patent · US Active

Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

US8080580B2 · kind B2 · utility

21Cited by
50References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2009
Grant dateDec 20, 2011
Priority date—
Expiry dateJul 13, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.